VaramirStart free · no cardSign in
ARQT as of Nov 2 · 12:35 ET
ARQTNasdaqPharmaceutical Preparations

Arcutis Biotherapeutics, Inc. · Brief

Next report

1 day

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±13.2%
avg realized
±9.4%
Aug 14 '24±12.6%▼−11.27%×0.90
Nov 6 '24±15.0%▲+7.66%×0.51
Feb 25 '25±13.4%▲+8.36%×0.62
May 6 '25±15.5%▼−4.33%×0.28
Aug 6 '25±10.0%▼−8.07%×0.81
Q3 FY25±15.7%▲+27.04%×1.72
Q1 FY26±13.1%▲+5.78%×0.44
Q2 FY26±10.2%▼−2.47%×0.24
quarterimplied−30%0+30%realized×
Q2 FY26±10.2%▼−2.47%×0.24
Q1 FY26±13.1%▲+5.78%×0.44
Q3 FY25±15.7%▲+27.04%×1.72
Aug '25±10.0%▼−8.07%×0.81
May '25±15.5%▼−4.33%×0.28
Feb '25±13.4%▲+8.36%×0.62
2 older reports
Nov '24±15.0%▲+7.66%×0.51
Aug '24±12.6%▼−11.27%×0.90
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2 of 3

4tracked funds holding ARQTN-PORT · Aug 31 '26
+4.34%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

6 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
31managers whose positions together make up four fifths of reported value13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

ARQT report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 27impliedImplied move: ±10.3% into Nov 3 earnings (Oct 27 close).Source
Oct 13impliedImplied move: ±14.0% into Oct 27 earnings (Oct 13 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.